Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Biopsy Market

4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Cancer Biopsy Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
    5.1. Cancer Prevalence & Incidence, by Region
    5.2. Technological Advancements
    5.3. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
    5.4. Reimbursement Scenario by Region/Globally
    5.5. Value Chain Analysis

6. Global Cancer Biopsy Market Analysis and Forecast, by Product
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Product, 2017-2031
        6.3.1. Platforms & Instruments
        6.3.2. Kits & Reagents
        6.3.3. Services
    6.4. Market Attractiveness Analysis, by Product

7. Global Cancer Biopsy Market Analysis and Forecast, by Type
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Type, 2017-2031
        7.3.1. Tissue Biopsies
            7.3.1.1. Needle Biopsies
            7.3.1.2. Surgical Biopsies
        7.3.2. Liquid Biopsies
        7.3.3. Others
    7.4. Market Attractiveness Analysis, by Type

8. Global Cancer Biopsy Market Analysis and Forecast, by Application
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Application, 2017-2031
        8.3.1. Breast Cancer
        8.3.2. Colorectal Cancer
        8.3.3. Cervical Cancer
        8.3.4. Lung Cancer
        8.3.5. Prostate Cancer
        8.3.6. Skin Cancer
        8.3.7. Blood Cancer
        8.3.8. Kidney Cancer
        8.3.9. Liver Cancer
        8.3.10. Pancreatic Cancer
        8.3.11. Ovarian Cancer
        8.3.12. Others
    8.4. Market Attractiveness Analysis, by Application

9. Global Cancer Biopsy Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region, 2017-2031
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region

10. North America Cancer Biopsy Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product, 2017-2031
        10.2.1. Platforms & Instruments
        10.2.2. Kits & Reagents
        10.2.3. Services
    10.3. Market Value Forecast, by Type, 2017-2031
        10.3.1. Tissue Biopsies
            10.3.1.1. Needle Biopsies
            10.3.1.2. Surgical Biopsies
        10.3.2. Liquid Biopsies
        10.3.3. Others
    10.4. Market Value Forecast, by Application, 2017-2031
        10.4.1. Breast Cancer
        10.4.2. Colorectal Cancer
        10.4.3. Cervical Cancer
        10.4.4. Lung Cancer
        10.4.5. Prostate Cancer
        10.4.6. Skin Cancer
        10.4.7. Blood Cancer
        10.4.8. Kidney Cancer
        10.4.9. Liver Cancer
        10.4.10. Pancreatic Cancer
        10.4.11. Ovarian Cancer
        10.4.12. Others
    10.5. Market Value Forecast, by Country, 2017-2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product
        10.6.2. By Type
        10.6.3. By Application
        10.6.4. By Country

11. Europe Cancer Biopsy Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product, 2017-2031
        11.2.1. Platforms & Instruments
        11.2.2. Kits & Reagents
        11.2.3. Services
    11.3. Market Value Forecast, by Type, 2017-2031
        11.3.1. Tissue Biopsies
            11.3.1.1. Needle Biopsies
            11.3.1.2. Surgical Biopsies
        11.3.2. Liquid Biopsies
        11.3.3. Others
    11.4. Market Value Forecast, by Application, 2017-2031
        11.4.1. Breast Cancer
        11.4.2. Colorectal Cancer
        11.4.3. Cervical Cancer
        11.4.4. Lung Cancer
        11.4.5. Prostate Cancer
        11.4.6. Skin Cancer
        11.4.7. Blood Cancer
        11.4.8. Kidney Cancer
        11.4.9. Liver Cancer
        11.4.10. Pancreatic Cancer
        11.4.11. Ovarian Cancer
        11.4.12. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product
        11.6.2. By Type
        11.6.3. By Application
        11.6.4. By Country/Sub-region
12. Asia Pacific Cancer Biopsy Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product, 2017-2031
        12.2.1. Instruments
        12.2.2. Kits & Reagents
        12.2.3. Services
    12.3. Market Value Forecast, by Type, 2017-2031
        12.3.1. Tissue Biopsies
            12.3.1.1. Needle Biopsies
            12.3.1.2. Surgical Biopsies
        12.3.2. Liquid Biopsies
        12.3.3. Others
    12.4. Market Value Forecast, by Application, 2017-2031
        12.4.1. Breast Cancer
        12.4.2. Colorectal Cancer
        12.4.3. Cervical Cancer
        12.4.4. Lung Cancer
        12.4.5. Prostate Cancer
        12.4.6. Skin Cancer
        12.4.7. Blood Cancer
        12.4.8. Kidney Cancer
        12.4.9. Liver Cancer
        12.4.10. Pancreatic Cancer
        12.4.11. Ovarian Cancer
        12.4.12. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product
        12.6.2. By Type
        12.6.3. By Application
        12.6.4. By Country/Sub-region
13. Latin America Cancer Biopsy Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product, 2017-2031
        13.2.1. Platforms & Platforms & Instruments
        13.2.2. Kits & Reagents
        13.2.3. Services
    13.3. Market Value Forecast, by Type, 2017-2031
        13.3.1. Tissue Biopsies
            13.3.1.1. Needle Biopsies
            13.3.1.2. Surgical Biopsies
        13.3.2. Liquid Biopsies
        13.3.3. Others
    13.4. Market Value Forecast, by Application, 2017-2031
        13.4.1. Breast Cancer
        13.4.2. Colorectal Cancer
        13.4.3. Cervical Cancer
        13.4.4. Lung Cancer
        13.4.5. Prostate Cancer
        13.4.6. Skin Cancer
        13.4.7. Blood Cancer
        13.4.8. Kidney Cancer
        13.4.9. Liver Cancer
        13.4.10. Pancreatic Cancer
        13.4.11. Ovarian Cancer
        13.4.12. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product
        13.6.2. By Type
        13.6.3. By Application
        13.6.4. By Country/Sub-region
14. Middle East & Africa Cancer Biopsy Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product, 2017-2031
        14.2.1. Platforms & Instruments
        14.2.2. Kits & Reagents
        14.2.3. Services
    14.3. Market Value Forecast, by Type, 2017-2031
        14.3.1. Tissue Biopsies
            14.3.1.1. Needle Biopsies
            14.3.1.2. Surgical Biopsies
        14.3.2. Liquid Biopsies
        14.3.3. Others
    14.4. Market Value Forecast, by Application, 2017-2031
        14.4.1. Breast Cancer
        14.4.2. Colorectal Cancer
        14.4.3. Cervical Cancer
        14.4.4. Lung Cancer
        14.4.5. Prostate Cancer
        14.4.6. Skin Cancer
        14.4.7. Blood Cancer
        14.4.8. Kidney Cancer
        14.4.9. Liver Cancer
        14.4.10. Pancreatic Cancer
        14.4.11. Ovarian Cancer
        14.4.12. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product
        14.6.2. By Type
        14.6.3. By Application
        14.6.4. By Country/Sub-region

15. Competition Landscape
    15.1. Market Player - Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company, 2022
    15.3. Company Profiles
        15.3.1. Abbott Laboratories
            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.1.2. Product Portfolio
            15.3.1.3. Financial Overview
            15.3.1.4. SWOT Analysis
            15.3.1.5. Strategic Overview
        15.3.2. Becton, Dickinson and Company
            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.2.2. Product Portfolio
            15.3.2.3. Financial Overview
            15.3.2.4. SWOT Analysis
            15.3.2.5. Strategic Overview
        15.3.3. F. Hoffmann-La Roche Ltd.
            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.3.2. Product Portfolio
            15.3.3.3. Financial Overview
            15.3.3.4. SWOT Analysis
            15.3.3.5. Strategic Overview
        15.3.4. Hologic, Inc.
            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.4.2. Product Portfolio
            15.3.4.3. Financial Overview
            15.3.4.4. SWOT Analysis
            15.3.4.5. Strategic Overview
        15.3.5. Danaher Corporation
            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.5.2. Product Portfolio
            15.3.5.3. Financial Overview
            15.3.5.4. SWOT Analysis
            15.3.5.5. Strategic Overview
        15.3.6. Thermo Fisher Scientific, Inc.
            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.6.2. Product Portfolio
            15.3.6.3. Financial Overview
            15.3.6.4. SWOT Analysis
            15.3.6.5. Strategic Overview
        15.3.7. Agilent Technologies, Inc.
            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.7.2. Product Portfolio
            15.3.7.3. Financial Overview
            15.3.7.4. SWOT Analysis
            15.3.7.5. Strategic Overview
        15.3.8. Illumina, Inc.
            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.8.2. Product Portfolio
            15.3.8.3. Financial Overview
            15.3.8.4. SWOT Analysis
            15.3.8.5. Strategic Overview
        15.3.9. Siemens Healthineers
            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.9.2. Product Portfolio
            15.3.9.3. Financial Overview
            15.3.9.4. SWOT Analysis
            15.3.9.5. Strategic Overview
        15.3.10. GE Healthcare
            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.10.2. Product Portfolio
            15.3.10.3. Financial Overview
            15.3.10.4. SWOT Analysis
            15.3.10.5. Strategic Overview
        15.3.11. Bio-Rad Laboratories, Inc.
            15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.11.2. Product Portfolio
            15.3.11.3. Financial Overview
            15.3.11.4. SWOT Analysis
            15.3.11.5. Strategic Overview
        15.3.12. Olympus Corporation
            15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.12.2. Product Portfolio
            15.3.12.3. Financial Overview
            15.3.12.4. SWOT Analysis
            15.3.12.5. Strategic Overview
        15.3.13. QIAGEN
            15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.3.13.2. Product Portfolio
            15.3.13.3. Financial Overview
            15.3.13.4. SWOT Analysis
            15.3.13.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031

Figure 02: Global Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031

Figure 03: Global Cancer Biopsy Market Revenue (US$ Mn), by Platforms & Instruments, 2017-2031

Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Kits & Reagents, 2017-2031

Figure 04: Global Cancer Biopsy Market Revenue (US$ Mn), by Services, 2017-2031

Figure 05: Global Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031

Figure 06: Global Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031

Figure 07: Global Cancer Biopsy Market Revenue (US$ Mn), by Tissue Biopsies, 2017-2031

Figure 08: Global Cancer Biopsy Market Revenue (US$ Mn), by Liquid Biopsies, 2017-2031

Figure 09: Global Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031

Figure 10: Global Cancer Biopsy Market Attractiveness Analysis, Application, 2023-2031

Figure 11: Global Cancer Biopsy Market Revenue (US$ Mn), by Breast Cancer, 2017-2031

Figure 12: Global Cancer Biopsy Market Revenue (US$ Mn), by Colorectal Cancer, 2017-2031

Figure 13: Global Cancer Biopsy Market Revenue (US$ Mn), by Cervical Cancer 2022 and 2031

Figure 14: Global Cancer Biopsy Market Revenue (US$ Mn), Lung Cancer, 2023-2031

Figure 15: Global Cancer Biopsy Market Revenue (US$ Mn), by Prostate Cancer, 2017-2031

Figure 16: Global Cancer Biopsy Market Revenue (US$ Mn), by Skin Cancer, 2017-2031

Figure 17: Global Cancer Biopsy Market Revenue (US$ Mn), by Blood Cancer, 2017-2031

Figure 18: Global Cancer Biopsy Market Revenue (US$ Mn), Kidney Cancer, 2023-2031

Figure 19: Global Cancer Biopsy Market Revenue (US$ Mn), by Liver Cancer, 2017-2031

Figure 20: Global Cancer Biopsy Market Revenue (US$ Mn), by Pancreatic Cancer, 2017-2031

Figure 21: Global Cancer Biopsy Market Revenue (US$ Mn), by Ovarian Cancer, 2017-2031

Figure 22: Global Cancer Biopsy Market Revenue (US$ Mn), by Others, 2017-2031

Figure 23: Global Cancer Biopsy Market Value Share Analysis, by Region, 2022 and 2031

Figure 24: Global Cancer Biopsy Market Attractiveness Analysis, by Region, 2023-2031

Figure 25: North America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031

Figure 26: North America Cancer Biopsy Market Value Share Analysis, by Country, 2022 and 2031

Figure 27: North America Cancer Biopsy Market Attractiveness Analysis, by Country, 2023-2031

Figure 28: North America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031

Figure 29: North America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031

Figure 30: North America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031

Figure 31: North America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031

Figure 32: North America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031

Figure 33: North America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031

Figure 34: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031

Figure 35: Europe Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 36: Europe Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 37: Europe Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031

Figure 38: Europe Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031

Figure 39: Europe Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031

Figure 40: Europe Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031

Figure 41: Europe Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031

Figure 42: Europe Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031

Figure 43: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031

Figure 44: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 45: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 46: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031

Figure 47: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031

Figure 48: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031

Figure 49: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Type, 2023-2031

Figure 50: Asia Pacific Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031

Figure 51: Asia Pacific Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031

Figure 52: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031

Figure 53: Latin America Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 54: Latin America Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 55: Latin America Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031

Figure 56: Latin America Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031

Figure 57: Latin America Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031

Figure 58: Latin America Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031

Figure 59: Latin America Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031

Figure 60: Latin America Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031

Figure 61: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, 2017-2031

Figure 62: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 63: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

Figure 64: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Product, 2022 and 2031

Figure 65: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Product, 2023-2031

Figure 66: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Type, 2022 and 2031

Figure 67: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, Type, 2023-2031

Figure 68: Middle East & Africa Cancer Biopsy Market Value Share Analysis, by Application, 2022 and 2031

Figure 69: Middle East & Africa Cancer Biopsy Market Attractiveness Analysis, by Application, 2023-2031

Figure 70: Global Cancer Biopsy Market Share Analysis, by Company 2022

List of Tables

List of Tables

Table 01: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 02: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 03: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 04: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 05: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 06: Global Cancer Biopsy Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 07: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 08: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 09: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 10: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 11: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 12: North America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 13: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 14: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 15: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 16: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 17: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 18: Europe Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 19: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 20: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 21: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 22: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 23: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 24: Asia Pacific Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 25: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 26: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 27: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 28: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 29: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 30: Latin America Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031

Table 31: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 32: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 33: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Type, 2017-2031

Table 34: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Application, 2017-2031

Table 35: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Tissue Biopsies, 2017-2031

Table 36: Middle East & Africa Cancer Biopsy Market Value (US$ Mn) Forecast, by Liquid Biopsies, 2017-2031